Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Azilsartan Tablets in Chinese Healthy Volunteers
NCT02786082Phase 1Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Nov 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of azilsartan in hypertension (HTN) (2 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Area Under Curve at 48 hours. Started Nov 2016; status: completed.
02
Drugs
azilsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02786082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786082.